Literature DB >> 1573231

Medulloblastoma: I. Clinical, diagnostic, and therapeutic overview.

F H Tomlinson1, B W Scheithauer, F B Meyer, W A Smithson, E G Shaw, G M Miller, R V Groover.   

Abstract

Medulloblastoma, the most common embryonal tumor of the central nervous system, affects both children and adults. It poses a significant therapeutic challenge in that age-dependent differences exist, not only in their pathobiology, but in the efficacy of chemotherapy and radiotherapy. This is particularly the case in very young children, whose still developing nervous system exhibits a low tolerance to radiotherapy. We review the epidemiology, clinical presentation, radiologic features, and current therapeutic concepts relative to this unique neoplasm. Efforts are made to highlight clinical controversies.

Entities:  

Mesh:

Year:  1992        PMID: 1573231     DOI: 10.1177/088307389200700203

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

1.  Reirradiation of Pediatric Tumors Using Hypofractionated Stereotactic Radiotherapy.

Authors:  Melis Gultekin; Mustafa Cengiz; Duygu Sezen; Faruk Zorlu; Ferah Yildiz; Gozde Yazici; Pervin Hurmuz; Gokhan Ozyigit; Fadil Akyol; Murat Gurkaynak
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

2.  Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats.

Authors:  C Bethune; A Blum; J R Geyer; J R Silber; R J Ho
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

3.  Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).

Authors:  R L Kenigsberg; Y Hong; H Yao; N Lemieux; J Michaud; C Tautu; Y Théorêt
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 4.  Cellular and molecular pathology of medulloblastoma.

Authors:  J P Provias; L E Becker
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

5.  Effects of basic fibroblastic growth factor on the growth of human medulloblastoma xenografts.

Authors:  Pascal Vachon; Christiane Girard; Yves Théorêt
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

6.  XNEOr: development and evaluation of an expert system to improve the quality and cost of decision-making in neuro-oncology.

Authors:  B L Maria; F A Lambay; D Dankel; S Chakravarthy; S Tufekci; R Marcus; A Kedar
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1994

Review 7.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

8.  Reirradiation of relapsed brain tumors in children.

Authors:  Marzanna Chojnacka; Anna Skowrońska-Gardas; Katarzyna Pędziwiatr; Marzena Morawska-Kaczyńska; Marta Perek; Danuta Perek
Journal:  Rep Pract Oncol Radiother       Date:  2011-11-13

Review 9.  Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.

Authors:  Edward Rustamzadeh; Chunbin Li; Sekou Doumbia; Walter A Hall; Daniel A Vallera
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

Review 10.  Targeting the Hedgehog Pathway in Pediatric Medulloblastoma.

Authors:  Sherri Y Huang; Jer-Yen Yang
Journal:  Cancers (Basel)       Date:  2015-10-23       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.